Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
travoprost, Quantity: 40 microgram/mL; timolol maleate, Quantity: 6.8 mg/mL (Equivalent: timolol, Qty 5 mg/mL)
Novartis Pharmaceuticals Australia Pty Ltd
Timolol maleate,Travoprost
Eye Drops, solution
Excipient Ingredients: ethoxylated hydrogenated castor oil; sodium hydroxide; propylene glycol; hydrochloric acid; sodium chloride; mannitol; boric acid; purified water; polyquaternium-1
Ophthalmic
2.5 ml x 1
(S4) Prescription Only Medicine
DuoTrav is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension for whom single agent therapy provides insufficient intraocular pressure reduction.
Visual Identification: Colourless to light yellow aqueous solution.; Container Type: Bottle; Container Material: PP; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Registered
2012-03-15
DUOTRAV ® EYE DROPS _travoprost 0.004% and timolol 0.5%_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET READ THIS LEAFLET CAREFULLY BEFORE YOU START TO USE DUOTRAV EYE DROPS. This leaflet answers some common questions about DuoTrav Eye Drops. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available. YOU SHOULD ENSURE THAT YOU SPEAK TO YOUR PHARMACIST OR DOCTOR TO OBTAIN THE MOST UP TO DATE INFORMATION ON THE MEDICINE. YOU CAN ALSO DOWNLOAD THE MOST UP TO DATE LEAFLET IN AUSTRALIA FROM WWW.NOVARTIS.COM.AU AND WWW.MEDSAFE.GOVT.NZ IN NEW ZEALAND. The updates may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the risks of you using DuoTrav against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT DUOTRAV IS USED FOR DuoTrav Eye Drops are used to lower pressure in the eye and to treat glaucoma. Glaucoma is a condition in which the pressure of the fluid in the eye may be high. However, some people with glaucoma may have normal eye pressure. Also, some people with raised eye pressure may not have glaucoma. DuoTrav Eye Drops contain two active ingredients, travoprost and timolol, that lower the pressure in the eye. Travoprost belongs to a family of medicines known as 'prostaglandins'. Timolol belongs to a family of medicines known as 'beta- blockers'. DuoTrav Eye Drops lower the pressure within the eye by two processes. They improve the flow of fluid from your eye(s) (travoprost) and decrease the production of fluid (timolol). Although DuoTrav Eye Drops help to control your glaucoma they do not cure it. Before prescribing DuoTrav Eye Drops for you, your d Διαβάστε το πλήρες έγγραφο
1 AUSTRALIAN PRODUCT INFORMATION – DUOTRAV (TRAVOPROST AND TIMOLOL MALEATE) EYE DROPS, SOLUTION 1 NAME OF THE MEDICINE travoprost and timolol maleate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION DuoTrav Eye Drops is a combination eye drop containing a topical prostaglandin analogue, travoprost and a topical beta-adrenergic receptor blocking agent, timolol maleate. Each mL of DuoTrav Eye Drops contains 40 micrograms (0.004%) travoprost and 5 mg (0.5%) timolol (as timolol maleate 6.83 mg). It is a sterile, isotonic aqueous solution with a buffered pH of approximately 6.8 and an osmolality of approximately 290 mOsmol/kg. The product is benzalkonium chloride (BAK) free and uses polyquaternium-1(POLYQUAD) as a preservative._ _ For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Eye drops, solution. Colourless to light yellow aqueous solution._ _ 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension for whom single agent therapy provides insufficient intraocular pressure reduction. 4.2 D OSE AND METHOD OF ADMINISTRATION _RECOMMENDED DOSAGE FOR ADULTS (INCLUDING THE ELDERLY) _ Instil one drop of DuoTrav Eye Drops once daily at about the same time each day in the conjunctival sac of the affected eye(s). DuoTrav Eye Drops should not be given more than once daily because travoprost is most effective at this dosage. If there is inadequate response to DuoTrav Eye Drops consideration should be given to using the individual agents with timolol dosed twice daily. If more than one topical ophthalmic product is being used, the eye drop products should be administered at least five minutes apart. 2 _SWITCHING TO THERAPY WITH DUOTRAV_ _ _ _EYE DROPS _ When substituting another ophthalmic antiglaucoma agent with DuoTrav Eye Drops, discontinue the other agent and start the following day with DuoTrav Eye Drops. 4.3 C ONTRAINDICATIONS DuoTrav Eye Drops are contraindicated in patients with a known Διαβάστε το πλήρες έγγραφο